TSHR and Graves disease: TSHr stimulation increased in vitro SOD release and the 4-HNE, which was confirmed by the in vivo measurements showing higher oxidative stress markers, such as malondialdehyde, 8-isoprostane and 8-hydroxy-2-deoxy guanosine in the urine of patients with untreated Graves’ disease.